Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Maureen Menwa Achebe, M.B.,B.S.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Desai RJ, Mahesri M, Globe D, Mutebi A, Bohn R, Achebe M, Levin R, Schneeweiss S. Clinical outcomes and healthcare utilization in patients with sickle cell disease: a nationwide cohort study of Medicaid beneficiaries. Ann Hematol. 2020 Sep 01. PMID: 32869184.
    Citations:    
  2. Achebe MM, Glaspy J, Kalra PA, Auerbach M, Thomsen LL, Bhandari S. A 6 month extension trial evaluating safety and efficacy of ferric derisomaltose in patients with iron deficiency anemia: The FERWON-EXT trial. Am J Hematol. 2020 Jun 29. PMID: 32602177.
    Citations:    
  3. Achebe M, DeLoughery TG. Clinical data for intravenous iron - debunking the hype around hypersensitivity. Transfusion. 2020 Jun; 60(6):1154-1159. PMID: 32479668.
    Citations:    
  4. Kumar V, Chaudhary N, Achebe MM. Epidemiology and Predictors of all-cause 30-Day readmission in patients with sickle cell crisis. Sci Rep. 2020 02 07; 10(1):2082. PMID: 32034210.
    Citations:    
  5. Wolf M, Rubin J, Achebe M, Econs MJ, Peacock M, Imel EA, Thomsen LL, Carpenter TO, Weber T, Brandenburg V, Zoller H. Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials. JAMA. 2020 02 04; 323(5):432-443. PMID: 32016310.
    Citations:    
  6. Olaniran KO, Allegretti AS, Zhao SH, Achebe MM, Eneanya ND, Thadhani RI, Nigwekar SU, Kalim S. Kidney Function Decline among Black Patients with Sickle Cell Trait and Sickle Cell Disease: An Observational Cohort Study. J Am Soc Nephrol. 2020 02; 31(2):393-404. PMID: 31810990.
    Citations:    
  7. Nze C, Fortin B, Freedman R, Mandell E, Puligandla M, Neuberg D, Achebe M. Sudden death in sickle cell disease: current experience. Br J Haematol. 2020 02; 188(4):e43-e45. PMID: 31804704.
    Citations:    
  8. Auerbach M, Henry D, Derman RJ, Achebe MM, Thomsen LL, Glaspy J. A prospective, multi-center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON-IDA trial. Am J Hematol. 2019 09; 94(9):1007-1014. PMID: 31243803.
    Citations:    
  9. Vichinsky E, Hoppe CC, Ataga KI, Ware RE, Nduba V, El-Beshlawy A, Hassab H, Achebe MM, Alkindi S, Brown RC, Diuguid DL, Telfer P, Tsitsikas DA, Elghandour A, Gordeuk VR, Kanter J, Abboud MR, Lehrer-Graiwer J, Tonda M, Intondi A, Tong B, Howard J. A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. N Engl J Med. 2019 08 08; 381(6):509-519. PMID: 31199090.
    Citations:    
  10. Olaniran KO, Eneanya ND, Allegretti AS, Zhao SH, Achebe MM, Thadhani RI. Cardiovascular Outcomes in African Americans with Sickle Cell Trait and Chronic Kidney Disease. Am J Nephrol. 2019; 49(2):93-102. PMID: 30625463.
    Citations:    Fields:    
  11. Olaniran KO, Eneanya ND, Nigwekar SU, Vela-Parada XF, Achebe MM, Sharma A, Thadhani RI. Sickle Cell Nephropathy in the Pediatric Population. Blood Purif. 2019; 47(1-3):205-213. PMID: 30517931.
    Citations:    Fields:    
  12. Derman R, Roman E, Smith-Nguyen GN, Achebe MM, Thomsen LL, Auerbach M. Iron isomaltoside is superior to iron sucrose in increasing hemoglobin in gynecological patients with iron deficiency anemia. Am J Hematol. 2018 06; 93(6):E148-E150. PMID: 29569727.
    Citations:    
  13. Field JJ, Majerus E, Gordeuk VR, Gowhari M, Hoppe C, Heeney MM, Achebe M, George A, Chu H, Sheehan B, Puligandla M, Neuberg D, Lin G, Linden J, Nathan DG. Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease. Blood Adv. 2017 Sep 12; 1(20):1645-1649. PMID: 29296811.
    Citations: 1     
  14. Gansner JM, Achebe MM, Gray KJ, Yefidoff-Freedman R, Labovitis E, Parnes A, Connors JM, Connell NT, Discenza MN, Handin RI, Berliner N, Shimamura A, Ginsburg ES, Smith NA. Pregnancy outcomes in inherited bone marrow failure syndromes. Blood. 2017 10 05; 130(14):1671-1674. PMID: 28798157.
    Citations: 1     Fields:    Translation:Humans
  15. Okam MM, Koch TA, Tran MH. Iron Supplementation, Response in Iron-Deficiency Anemia: Analysis of Five Trials. Am J Med. 2017 08; 130(8):991.e1-991.e8. PMID: 28454902.
    Citations:    Fields:    Translation:Humans
  16. Derman R, Roman E, Modiano MR, Achebe MM, Thomsen LL, Auerbach M. A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia. Am J Hematol. 2017 03; 92(3):286-291. PMID: 28052413.
    Citations:    
  17. Achebe MM, Gafter-Gvili A. How I treat anemia in pregnancy: iron, cobalamin, and folate. Blood. 2017 02 23; 129(8):940-949. PMID: 28034892.
    Citations:    
  18. Okam MM, Koch TA, Tran MH. Iron deficiency anemia treatment response to oral iron therapy: a pooled analysis of five randomized controlled trials. Haematologica. 2016 Jan; 101(1):e6-7. PMID: 26518747.
    Citations: 3     Fields:    Translation:Humans
  19. Okam MM, Esrick EB, Mandell E, Campigotto F, Neuberg DS, Ebert BL. Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea. Blood. 2015 Jun 04; 125(23):3668-9. PMID: 26045597.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  20. Okam MM, Shaykevich S, Ebert BL, Zaslavsky AM, Ayanian JZ. National trends in hospitalizations for sickle cell disease in the United States following the FDA approval of hydroxyurea, 1998-2008. Med Care. 2014 Jul; 52(7):612-8. PMID: 24926708.
    Citations: 6     Fields:    Translation:Humans
  21. Field JJ, Lin G, Okam MM, Majerus E, Keefer J, Onyekwere O, Ross A, Campigotto F, Neuberg D, Linden J, Nathan DG. Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson. Blood. 2013 Apr 25; 121(17):3329-34. PMID: 23377438.
    Citations: 32     Fields:    Translation:HumansCellsCTClinical Trials
  22. Okam MM, Mandell E, Hevelone N, Wentz R, Ross A, Abel GA. Comparative rates of adverse events with different formulations of intravenous iron. Am J Hematol. 2012 Nov; 87(11):E123-4. PMID: 22965928.
    Citations: 5     Fields:    Translation:Humans
  23. Okam MM, Ebert BL. Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors. Expert Rev Hematol. 2012 Jun; 5(3):303-11. PMID: 22780210.
    Citations: 2     Fields:    Translation:HumansAnimals
  24. Styles L, Wager CG, Labotka RJ, Smith-Whitley K, Thompson AA, Lane PA, McMahon LE, Miller R, Roseff SD, Iyer RV, Hsu LL, Castro OL, Ataga KI, Onyekwere O, Okam M, Bellevue R, Miller ST. Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE). Br J Haematol. 2012 Jun; 157(5):627-36. PMID: 22463614.
    Citations: 10     Fields:    Translation:Humans
  25. Nathan DG, Field J, Lin G, Neuberg D, Majerus E, Onyekwere O, Keefer J, Okam M, Ross A, Linden J. Sickle cell disease (SCD), iNKT cells, and regadenoson infusion. Trans Am Clin Climatol Assoc. 2012; 123:312-7; discussion 317-8. PMID: 23303999.
    Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
  26. Lee AI, Okam MM. Anemia in pregnancy. Hematol Oncol Clin North Am. 2011 Apr; 25(2):241-59, vii. PMID: 21444028.
    Citations: 17     Fields:    Translation:Humans
  27. Gladwin MT, Kato GJ, Weiner D, Onyekwere OC, Dampier C, Hsu L, Hagar RW, Howard T, Nuss R, Okam MM, Tremonti CK, Berman B, Villella A, Krishnamurti L, Lanzkron S, Castro O, Gordeuk VR, Coles WA, Peters-Lawrence M, Nichols J, Hall MK, Hildesheim M, Blackwelder WC, Baldassarre J, Casella JF. Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial. JAMA. 2011 Mar 02; 305(9):893-902. PMID: 21364138.
    Citations: 45     Fields:    Translation:Humans
  28. Ng S, Fanta C, Okam M, Bhatt AS. NK-cell and B-cell deficiency with a thymic mass. N Engl J Med. 2011 Feb 10; 364(6):586-8. PMID: 21306273.
    Citations:    Fields:    Translation:HumansAnimalsCells
  29. Okam M, Alsolaiman M, Brau A, Austin M, Plymyer M. Spontaneous pneumothorax as the first manifestation of lymphoma: a rare presentation and the importance of diagnostic biopsy. South Med J. 2003 Jan; 96(1):99-100. PMID: 12602730.
    Citations:    Fields:    Translation:Humans
  30. H. Arjomand, J. AlSalman, M. Okam, R. Arjomand, K. Khalighi, S. Kutalek. Antibiotic Prophylaxis for Permanent Pacemaker Implantation. A prospective randomized. placebo controlled trial with topical antibiotics and skin antiseptics. PACE. 2001; 24(Part II):583.
  31. Igbigbi PS and Okam MM. Estimation fo Lower Humeral Angle in Nigerians. West African Journal of Anatomy. 1994; 2(1):19-22.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Achebe's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (103)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.